WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women
NCT: NCT07675382 · COMPLETED
Brief Summary
This randomized controlled trial investigated the effects of an 8-week whole-body electromyostimulation (WB-EMS) combined with a hypocaloric diet on body composition, cardiometabolic markers, and serum levels of the myokines irisin and betatrophin (ANGPTL8) in women with obesity. Participants were randomly assigned to either a diet-only group or a diet plus WB-EMS group. WB-EMS sessions were conducted twice weekly (20-25 minutes per session) over 8 weeks. The primary outcomes included BMI, body fat percentage, lean body mass, fasting blood glucose, insulin, HOMA-IR, HbA1c, lipid profile, CRP, and serum irisin and betatrophin concentrations. The study aimed to evaluate whether WB-EMS adds metabolic and myokine-related benefits beyond those achieved by dietary restriction alone in obese women.
Frequently Asked Questions
What is WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women?
WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women is a clinical trial registered under NCT07675382. Current status: COMPLETED.
What is the status of NCT07675382?
The current status of NCT07675382 (WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women) is: COMPLETED.
When did WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women start?
WB-EMS and Diet Effects on Body Composition, Cardiometabolic Markers, and Myokines in Obese Women started on 2025-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.